Table 1

Demographic and pre-procedural information

CharacteristicNPercent
Total cases472
Gender
 Male23650
 Female23650
Age
 Mean±SD70±16
Anticoagulation status
 Warfarin5912.5
  Mean INR±SD (n=55)1.6±0.5
 Rivaroxaban10.2
 No prior anticoagulation41287.3
 Patients with INR>1.7285.9
Dual Antiplatelet therapy102.1
Thrombolytic therapy
 IA tPA10321.8
 IV tPA12326.1
 IV and IA tPA347.2
 No tPA21244.9
  • IA, intra-arterial; tPA, tissue Plasminogen Activator.